TOPK Inhibitor HI-TOP-32 administration in DEN-induced hepatocarcinogenesis in C57BL/6 mice results in tumour regression. (April 2016) - Giakoustidis, A.; Andreani, P.; Poutachidis, T.; Angelopoulou, K.; Mosialos, G.; Goulopoulos, T.; Papalois, A.; Papanikolaou, V.; Mudan, S.; Giakoustidis, D.; Azoulay, D.